Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The Diagnostic Testing Services segment engages in the selling of consumables used for collection, and promotion of pathology. The Imaging Services segment sells radio-pharmaceutical and consumables for reporting. The Others segment engages in the sale of testing equipment and consumables; and glucometer and glucostrips under the brand name sugarscan. The company offers diagnostic and pathological services. The company was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
| Current Price | ₹521.95 |
|---|---|
| Market Cap | ₹8,308 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Medical Laboratory Services |
| P/E Ratio | 51 |
| Return on Equity | 28.75% |
| Beta (1Y) | 0.89 |
| Dividend Yield | 2.68% |
Throcare Technologies Ltd is trading at ₹521.95, with a market capitalisation of ₹8,308 Cr.
Throcare Technologies Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Medical Laboratory Services).
Throcare Technologies Ltd has a P/E of 51 and a return on equity of 28.75%.